DEVELOPED WITH THE PHARMA LCA CONSORTIUM
AstraZeneca
Chiesi
GSK
Johnson & Johnson
Merck KGaA
MSD
Novartis
Novo Nordisk
Pfizer
Roche
Sanofi
Takeda Pharmaceuticals
PAS 2090: New standard for Pharma LCAs
PAS 2090 is the first sector-specific standard for pharmaceutical life cycle assessments, developed by the Pharma LCA Consortium and published by the British Standards Instituion at the end of 2025. It establishes a common methodology for measuring and reporting environmental impacts across the pharmaceutical value chain, enabling more consistent, transparent, and comparable LCAs.
PharmaLCA: From standard to software
Developed with the Pharma LCA Consortium, PharmaLCA transforms PAS 2090 from a published standard into a practical software. Guided workflows and built-in methodology empower both LCA experts and non-experts create compliant assessments across the whole pharmaceutical value chain.
Create your fist PAS 2090-complaint assessment.
Why PharmaLCA
Designed for the entire Pharma ecosystem
PAS 2090 built-in
All methodological requirements are translated directly into guided workflows. No need to read the standard yourself.
LCAs made practical
Perfect for small teams without an LCA expert on hand. Get started for free and create PAS-compliant LCAs with ease.
End-to-end LCA
Model, analyse, and report environmental impacts across the full pharmaceutical product life cycle.
Ecoinvent integrated
Access curated, high-quality secondary emission datasets directly in the tool — no separate licensing required.
Secure SaaS
Multi-tenant cloud architecture with strict data isolation and enterprise-grade access controls.
Expert flexibility
Advanced users retain full control for detailed modelling, without adding complexity for non-experts.
TRUST & SECURITY
Enterprise-grade security, by design
Your data is sensitive. PharmaLCA is built on AllocNow's secure, certified infrastructure — so you can focus on your LCAs.
ISO 27001 certified
AllocNow is ISO 27001 certified for information security management.
Strict data isolation
Multi-tenant architecture ensures complete separation between company accounts.
GDPR compliant
Full compliance with EU data protection regulation.
Enterprise access control
Role-based permissions and SSO-ready authentication.
EVENTS
Meet us
We regularly attend selected industry conferences and sustainability forums to connect with the pharmaceutical and life sciences community. Come meet our team in person to learn more about PharmaLCA, the PAS 2090 standard, and how our platform makes compliant life-cycle assessments accessible to everyone.
UP NEXT
CPHI Europe 2026
CPHI Europe 2026 is the premier pharmaceutical trade show in Europe, covering the entire pharma value chain — from active pharmaceutical ingredients (APIs), excipients, and fine chemicals to finished dosage forms. Together with representatives of the Pharma LCA Consortium, AllocNow will present PharmaLCA in two sessions — including the launch of the PharmaLCA application.
October 6, 2026
2:35 – 3:00 PM
Hall 16 - 16F60, Product Innovation Stage
Presentation of PharmaLCA with the Pharma LCA Consortium
Join us for the launch of the PharmaLCA application at CPHI, alongside representatives from Roche, Novartis, and GSK representing the Pharma LCA Consortium, as we advance sustainability and life cycle assessment across the pharmaceutical industry.
October 7, 2026
9:45 – 11:00 AM
Libra Room — Stella Polare, Sustainability Summit
Pharma LCA Consortium on PharmaLCA
Join us for an interactive demo session and deep dive into key modeling challenges across the pharmaceutical value chain. Discover how PharmaLCA supports robust, scalable sustainability assessments through practical examples and expert insights.
Access requires a Sustainability Summit pass.
Past Events
Pharma Sustainability Days
After months of development and testing, the first version of PharmaLCA was unveiled at Pharma Sustainability Days in Geneva in May 2026. Together with members of the Pharma LCA Consortium, we presented a live demo of the PharmaLCA MVP, demonstrating how PAS 2090 can be translated from methodology into practical software.
ACADEMY
LCA foundations, from theory to practice
LCA Training
New to life cycle assessment (LCA)? Our one-day live training takes you from the fundamentals to a working understanding of PAS 2090 — and shows you how to put it into practice with PharmaLCA. No prior LCA experience required. Taught live in a small group by a practicing LCA expert, so you can ask real questions and leave able to run your first assessment.
Who it's for
Built for newcomers. This course is designed for sustainability managers, environmental and QA teams, procurement professionals, and anyone across the pharma value chain who needs to understand LCA without a technical background. If you've been asked to "do an LCA" and aren't sure where to start, this is your starting point.
What you will learn
1
LCA fundamentals
What an LCA actually is, why it matters, and how one is performed. We walk through the four phases — goal and scope, inventory, impact assessment, and interpretation — and the core terminology, grounded in the ISO 14040/44 framework.
2
PAS 2090 in depth
The first sector-specific LCA standard for pharma, unpacked. What PAS 2090 requires, how this guideline builds on the ISO foundation, and what makes assessing pharmaceutical products distinct from other industries.
3
Modeling in PharmaLCA
Theory into practice. A hands-on walkthrough of turning what you've learned into a compliant assessment inside PharmaLCA — from data collection through to a PAS 2090-aligned result.
At a glance
Format Live, online (remote)
Duration Full day, 8 hours
Group size Limited to 10 seats
Prerequisites None
Price 850 EUR (excl. VAT)
Instructor bio
Simon Rauch, PhD, is an experienced LCA practitioner with a background in chemicals, gained at a leading chemical company. He brings the practitioner's perspective to every session — not just how the standards read on paper, but how assessments get done in the real world.
Dates and booking
The PharmaLCA Academy courses are conducted from 9 AM to 5 PM CET. Time slots for other time zones can be provided on request.
Frequently asked questions
What is PharmaLCA?
PharmaLCA is a PAS 2090-compliant life cycle assessment (LCA) software developed by AllocNow, built in close collaboration with the Pharma LCA Consortium. Its mission is to transform how the pharmaceutical industry measures and optimizes environmental impacts by making LCA accessible to all stakeholders across the pharma value chain, including global pharmaceutical companies, supply chain partners, contract manufacturing organizations (CMOs), and sustainability professionals at all levels of LCA expertise. PharmaLCA enables companies to generate LCAs for their entire product portfolio in full compliance with PAS 2090, the first sector-specific international standard for pharmaceutical LCA.
Who developed PharmaLCA?
PharmaLCA was developed by AllocNow, the globally leading LCA technology provider for the chemical, pharmaceutical, and process industries. AllocNow was selected by the Pharma LCA Consortium through a rigorous vetting process to develop and operate the PAS 2090-compliant LCA application for the pharmaceutical sector. The platform is built on AllocNow's proven Product Sustainability Platform, adapted specifically to the methodological requirements of PAS 2090 and the practical needs of pharmaceutical companies at all scales.
What is the Pharma LCA Consortium?
The Pharma LCA Consortium is a formal industry initiative of eleven leading global pharmaceutical companies, launched on November 1, 2023, under the banner of the Pharmaceutical Environment Group (PEG) and with support from the Sustainable Markets Initiative (SMI) Health Systems Task Force. The Consortium's purpose is to facilitate a universal approach to assessing the environmental impact of pharmaceutical products, enabling pharmaceutical companies and their stakeholders to make informed choices about product development and patient care. The Pharma LCA Consortium consists of twelve member companies: AstraZeneca, Chiesi, GSK, Johnson & Johnson, Merck KGaA, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and Takeda Pharmaceuticals. These companies collectively represent a significant share of global pharmaceutical production and have committed to developing and adopting a universal, harmonized approach to environmental LCA for pharmaceutical products. The Consortium operates under the Pharmaceutical Environment Group (PEG) with support from the Sustainable Markets Initiative (SMI).
What is the vision and mission of PharmaLCA?
The vision of PharmaLCA is "From Theory to Practice: Practical Enablement of PAS 2090 Aligned LCAs for Pharmaceutical Products." Its mission is to transform how the pharmaceutical industry measures and optimizes environmental impacts by accelerating the adoption of life cycle assessment, and making it accessible to all stakeholders across the pharma ecosystem, from pharmaceutical companies and supply chain partners to contract manufacturers and industry professionals at every level of LCA expertise.
What are the strategic objectives of PharmaLCA?
PharmaLCA pursues two interconnected sets of strategic objectives. The first is to break through the barriers that have historically limited LCA adoption in pharma: overcoming the technical challenges unique to medicine environmental LCA, delivering streamlined yet scientifically robust pharmaceutical footprinting solutions, and bridging the expertise gap in LCA execution by making PAS 2090 a practical enabler rather than a compliance burden. The second is to drive broader pharmaceutical industry evolution: championing PAS 2090 adoption from theory to practical execution, engaging pharmaceutical stakeholders at all levels through environmental LCA, and pioneering the industry's transition from carbon-specific metrics to comprehensive multi-impact environmental assessment.
Who is PharmaLCA designed for?
PharmaLCA is designed for every organization across the pharmaceutical value chain, not just large global companies with in-house LCA expertise. The platform is accessible to global pharmaceutical manufacturers, small and medium-sized enterprises (SMEs), contract manufacturing organizations (CMOs), and sustainability professionals at all levels of LCA experience. For non-experts, PharmaLCA guides users through compliant PAS 2090 assessments step by step without requiring deep technical LCA knowledge. For advanced users, the platform retains full control for detailed modeling. This universal accessibility is central to the mission of both PharmaLCA and the Pharma LCA Consortium.
Does PharmaLCA require LCA expertise to use?
No. PharmaLCA is specifically designed to be accessible to sustainability managers, environmental teams, and procurement professionals who are not LCA experts. All PAS 2090 methodological requirements are translated directly into guided, step-by-step workflows within the platform, so users do not need to read or interpret the standard themselves. For organizations without an in-house LCA specialist, PharmaLCA bridges the expertise gap and makes compliant pharmaceutical LCA achievable. At the same time, advanced users retain full control for detailed modeling, ensuring the platform serves the full spectrum of user sophistication without adding complexity for non-experts.
What secondary data does PharmaLCA provide?
The free Starter Plan includes the open-source BAFU database at no additional cost. The Professional Plan adds access to a curated subset of ecoinvent with full LCIA results. For advanced chemical modeling, users can extend PharmaLCA with the Carbon Minds cm.chemicals add-on.
How does PharmaLCA handle data security and privacy?
PharmaLCA is built on AllocNow's secure, ISO 27001-certified infrastructure. The platform uses a multi-tenant cloud architecture with strict data isolation between company accounts, ensuring that one organization's data is never accessible to another. All data handling is GDPR compliant, with full alignment to EU data protection requirements. Enterprise-grade access controls include role-based permissions and SSO-ready authentication. AllocNow has successfully completed every customer security vetting process to date, demonstrating a consistent track record of meeting the highest enterprise security standards.
Has PharmaLCA been independently audited?
Yes. PharmaLCA has successfully undergone an independent evaluation by TÜV SÜD based on the requirements of PAS 2090.
How much does PharmaLCA cost?
PharmaLCA offers a free Starter Plan and a paid Professional Plan. The Starter Plan includes the BAFU database and is free forever. The Professional Plan costs €8,000 per user per year and provides access to premium datasets and advanced capabilities. Professional users can optionally add Carbon Minds cm.chemicals for €1,200 per user per year, including access to up to 100 datasets.